Big Movers: Moderna Rose, Palantir, and Applovin Fell

Investors speculated on Covid vaccine firms. Despite the seasonal strength for flu-related vaccines ending, Moderna (MRNA) gained 11.65% to close at $47.53. Pfizer (PFE), BioNTech (BNTX), Arcturus Therapeutics (ARCT), and Novavax (NVAX) rallied. The Centers for Disease Control and Prevention announced respiratory illness data in the last week. Covid infections are more frequent alongside a…

Read More

Winnebago Flat on Naming Peck to Board

Winnebago Industries, Inc. (NYSE: WGO) shares barely moved Wednesday, despite the announcement of Mike Pack, a senior executive for Oshkosh Corporation, to its board of directors. “Winnebago Industries is committed to continuing to be the trusted leader in outdoor recreation and Mike’s financial and management skillsets, as well as his manufacturing industry expertise, will be…

Read More

Watch Out For Higher Treasury Yields at 5.0%

Ahead of the U.S. Treasury auction, yields continued to climb. Markets traded lower on Tuesday, while Asia-Pacific markets opened lower in Wednesday morning trade. Samsung (SSNLF) managed to trade slightly higher, despite issuing a profit forecast for the fourth quarter that did not meet expectations. High U.S. treasury yields compete for investor money. Instead of…

Read More

GeneDX Slides on Asserting Industry Leadership Role

GeneDx (NASDAQ: WGS) shares fell Wednesday. The company, a leader in delivering improved health outcomes through genomic insights, continues its investment in advancing scientific discovery through understanding gene-disease relationships, contributing to more than 85 peer-reviewed publications in 2024. These contributions, added to GeneDx’s years of dedicated research efforts, influenced the broadening of phenotypes, the discovery…

Read More